Login

Dr Anil Diwan, CEO, NanoViricides Inc 00:00:00

Share On Facebook Share On Twitter

NanoViricides announces key data on Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights from Alain Barbezat - Senior Fund Manager at RAB Capital
00:00:00
Oliver Schacht, CEO, Curetis
00:00:00
Interview with Jodie Gilmore, Global Orthopedic Business Director at Elos Medtech
00:10:00
Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag
00:10:00
Dr. Andrew Tunks on Meteoric Resources' Cobalt Ventures: Unveiling Canada's Riches
00:10:00
Creactives Group Explores AI Challenges in the Supply Chain | Adriano Garibotto, Co-founder, Creactives Group S P A.
00:10:00
Navigating Financial Distress and Uncertainty in M&A
00:10:00
Madryn Asset Management is a leading alternative asset management firm that invests in innovative healthcare companies specializing in unique and transformative products, technologies, and services. The firm draws on its extensive and diverse experience s
00:10:00
Insights into Lodging Sector Resilience and Sustainability Strategies | Mark Brugger, CEO ,Diamondrock Hospitality Co.
00:10:00
Driving Innovation with Patient Capital: Insights from John Smith of the European Innovation Council Fund | John Smith - Investment Manager, European Innovation Council Fund
00:10:00
Exploring the Vision and Performance of a European REIT | Simon Garing, CEO, Cromwell European Real Estate Investment Trust.
00:10:00
Enhancing Client Convenience Through E-Signing Capabilities

© 2026 Nehu